Skip to content

Clinical trials

Phase 3 Genital Neoplasms, Female trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Genital Neoplasms, Female Phase: Phase 3 Clear all

7 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20022
20061
20101
20161
20181
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed4
Recruiting1
Unknown status1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Eli Lilly and Company2
Chiang Mai University1
Huazhong University of Science and Technology1
Lei Li1
Mabwell (Shanghai) Bioscience Co., Ltd.1
Odense University Hospital1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Genital Neoplasms, Female7
Ovarian Neoplasms3
Fallopian Tube Neoplasms2
Pelvic Neoplasms2
Peritoneal Neoplasms2
Uterine Cervical Neoplasms2
Endometrial Neoplasms1
Nausea1
Neoplasms1
Neoplasms by Site1

Trials

Showing 26 to 7 of 7. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.